High Triglycerides and Type 2 Diabetes: Risk Factor, Not Symptom

Elevated triglycerides (≥150 mg/dL) are a risk factor and component of insulin resistance syndrome, not a symptom of type 2 diabetes (T2D).

Pathophysiological Link

  • Insulin resistance: Impaired lipoprotein lipase (LPL) activation → reduced VLDL clearance → hypertriglyceridemia.
  • Hepatic overproduction: Insulin fails to suppress hepatic VLDL secretion; increased FFA flux from adipose.
  • Common soil: Visceral adiposity drives both hypertriglyceridemia and β-cell dysfunction → T2D.

Bidirectional Relationship

  • Hypertriglyceridemia → pancreatitis → β-cell damage → diabetes (rare).
  • T2D hyperglycemia → worsens hypertriglyceridemia (glucotoxicity).

Metabolic Syndrome Criteria (ATP III)

≥3 of: waist >102/88 cm (M/F), TG ≥150, HDL <40/50, BP ≥130/85, fasting glucose ≥100.

Clinical Implications

  • High TG + low HDL = atherogenic dyslipidemia → residual CV risk despite LDL control.
  • TG >500 mg/dL: pancreatitis risk; treat with fibrates, omega-3s, strict diet.
  • TG 150–499: intensify lifestyle; consider icosapent ethyl (CV benefit in REDUCE-IT).

Lifestyle Interventions

  • Weight loss 5–10% → 20–50% TG reduction.
  • Low refined carbs/sugars; Mediterranean diet.
  • Exercise: aerobic + resistance.
  • Alcohol restriction (potent TG elevator).
  • Omega-3 (EPA/DHA) 2–4 g/day prescription grade.

Screening: lipid panel annually in adults; earlier with risk factors. Treat TG as modifiable risk marker, not a diabetic symptom.

Diabetes - Related Articles